Simple questionnaire could bring palliative care home for lung disease patients
NCT ID NCT06714188
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a simple questionnaire to help match newly diagnosed idiopathic pulmonary fibrosis (IPF) patients to the right level of palliative care. Researchers asked 30 patients a few questions to see if the tool could predict their needs as accurately as a doctor's judgment. The goal is to make palliative care more personalized and accessible, potentially allowing some patients to receive care at home.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this tool could help doctors quickly identify each IPF patient's palliative care needs, allowing some to receive care at home instead of in the hospital.
- What could go wrong
- This is a small, early study with only 30 participants. The questionnaire may not match expert judgment well, and results may not apply to all IPF patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IPF are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Azienda Ospedaliera-Universitaria di Bologna
Bologna, Bologna, 40138, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a breath test predict lung scarring? new study seeks answers
- New inhaled drug for lung disease tested in healthy people first
- New hope for lung scarring: HSK44459 enters final trial phase
- Healthy volunteers to test experimental lung disease drug
- New drug for lung scarring takes first step in healthy volunteers
- New drug MN-001 tested for scarred lungs in tiny trial